You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 150 No. 1, January 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (80)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Diabetic Nephropathy

An Update

Alluru S. Reddi, MD, PhD; Rafael A. Camerini-Davalos, MD, DSc

Arch Intern Med. 1990;150(1):31-43.


Abstract



• Nephropathy is a serious microvascular complication in patients with insulin-dependent diabetes mellitus. In the United States, diabetes accounts for one fourth of new cases of end-stage renal disease each year. Complication rates and costs are much higher for diabetic than for nondiabetic patients with end-stage renal disease. Despite numerous studies, the pathophysiology of diabetic renal disease is not completely understood. We reviewed the current status of the structural, functional, biochemical, pathogenetic, and treatment modalities of diabetic renal disease and examined future therapeutic interventions.

(Arch Intern Med. 1990;150:31-43)



Author Affiliations



From the Division of Nephrology, Department of Medicine, University of Medicine and Dentistry–New Jersey Medical School, Newark (Dr Reddi); and the Department of Medicine, Metropolitan Hospital Research Center, New York, NY (Dr Camerini-Davalos).


Footnotes



Accepted for publication March 15,1989.

Reprint requests to Department of Medicine, UMD-New Jersey Medical School, 185 S Orange Ave, Newark, NJ 07103-2757 (Dr Reddi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Connective Tissue Growth Factor and IGF-I Are Produced by Human Renal Fibroblasts and Cooperate in the Induction of Collagen Production by High Glucose
Lam et al.
Diabetes 2003;52:2975-2983.
ABSTRACT | FULL TEXT  

Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension
Reddi et al.
Hypertension 2000;36:233-238.
ABSTRACT | FULL TEXT  

Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats
Jyothirmayi et al.
Hypertension 1996;27:1108-1114.
ABSTRACT | FULL TEXT  

Diabetic Nephropathy: The Internist's Role
ROCHER
Arch Intern Med 1990;150:26-28.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.